Aminosalicylate Potassium

CHEMBL1200584 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
191.2 g/mol
LogP
Phase
4

The potassium salt form of para-aminosalicylic acid, a second-line antibiotic used to treat tuberculosis in combination with other antituberculosis drugs, particularly in cases of drug-resistant TB. It inhibits mycobacterial folic acid synthesis and iron uptake, slowing the growth of Mycobacterium tuberculosis.

Peso Molecular

191,2300 g/mol

TPSA

86,40 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Nc1ccc(C(=O)[O-])c(O)c1.[K+]

InChI

InChI=1S/C7H7NO3.K/c8-4-1-2-5(7(10)11)6(9)3-4;/h1-3,9H,8H2,(H,10,11);/q;+1/p-1

Molecular Formula

C7H6KNO3

HBD / HBA

2 / 4

Ligações Rotacionáveis

1

Átomos Pesados

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

The potassium salt form of para-aminosalicylic acid, a second-line antibiotic used to treat tuberculosis in combination with other antituberculosis drugs, particularly in cases of drug-resistant TB. It inhibits mycobacterial folic acid synthesis and iron uptake, slowing the growth of Mycobacterium tuberculosis.

Yes, Aminosalicylate Potassium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200584. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23690428. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.